Genetic Testing Market Outlook 2032: Role of Lab-on-Chip and Point-of-Care Diagnostics

Genetic Testing Market Outlook 2032: Role of Lab-on-Chip and Point-of-Care Diagnostics, updated 7/11/25, 5:40 AM

categoryOther
visibility1

Tag Cloud


https://www.fortunebusinessinsights.com/genetic-testing-service-market-105590

Genetic Testing Market Trends 2032: AI-Based
Variant Interpretation Enhances Accuracy
The Genetic Testing Market is growing rapidly as healthcare embraces precision medicine and preventive
care. These services include predictive risk assessments, carrier screening, pharmacogenomic profiling,
oncology panels, and ancestry testing. Fueling this growth are technological breakthroughs like next-
generation sequencing (NGS) and whole-exome sequencing, reduced testing costs, rising genetic disorder
prevalence, and expanding direct-to-consumer (DTC) access. North America leads the market, while Asia-
Pacific shows the quickest expansion. With continued innovation, increased patient awareness, and
supportive genomic initiatives, genetic testing is becoming a cornerstone of modern diagnostics and
personalized healthcare.
According to Fortune Business Insights, the global genetic testing market was valued at USD 33.82 billion in
2024. The market is projected to grow from USD 37.32 billion in 2025 to USD 76.09 billion by 2032,
exhibiting a CAGR of 10.7% during the forecast period. In 2024, North America dominated the genetic
testing market with a market share of 41.72%.